CNP-MYG (Myasthenia Gravis)

CNP-MYG is a first-in-class therapeutic designed to reprogram the immune system to address the immunological root cause of disease in Myasthenia Gravis. CNP-MYG is the only antigen specific treatment option which can prevent immune mediated neuromuscular destruction.